Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer.
Keisuke TsuchidaKouji InabaTairo KashiharaNaoya MurakamiKae OkumaKana TakahashiHiroshi IgakiYuko NakayamaAiko MaejimaYasuo ShinodaYoshiyuki MatsuiMotokiyo KomiyamaHiroyuki FujimotoYoshinori ItoMinako SumiTakashi NakanoJun ItamiPublished in: Cancer medicine (2020)
RT dose escalation to metastatic LN in cN1 patients improves BRFS, RFS, and DMFS at 4 and 7 years, without increasing severe adverse events.
Keyphrases
- prostate cancer
- lymph node
- end stage renal disease
- squamous cell carcinoma
- small cell lung cancer
- locally advanced
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early stage
- rectal cancer
- peritoneal dialysis
- randomized controlled trial
- neoadjuvant chemotherapy
- lymph node metastasis
- clinical trial
- sentinel lymph node